6/3/26 18:52 | 6/1/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | | 1 | S | -198 | 50.55 | 0 | -4 | | 284 | D | | | | | | | | | | | | | | |
6/3/26 18:51 | 6/1/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Eckhardt Sue Gail | CA | D | | 1 | S | -492 | 50.14 | 0 | -10 | | 16 | D | | | | | | | | | | | | | | |
5/28/26 18:25 | 5/26/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | EVP,Rese | 1 | S | -2,188 | 50.35 | 0 | -43 | | 601 | D | | | | | | | | | | | | | | |
5/22/26 17:01 | 5/20/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Haley Patrick J. | CA | O | EVP,Comm | 1 | S | -1,599 | 49.81 | 0 | -32 | | 358 | D | | | | | | | | | | | | | | |
5/19/26 18:58 | 5/18/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Senner Christopher J. | CA | O | EVP,CFO | 1 | S | -1,745 | 50.00 | 0 | -35 | | 955 | D | | | | | | | | | | | | | | |
5/19/26 18:58 | 5/18/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Hefti Brenda | CA | O | SVP,GC | 1 | S | -333 | 50.21 | 0 | -7 | | 112 | D | | | | | | | | | | | | | | |
5/8/26 19:03 | 5/7/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Beckerle Mary C | CA | D | | 2 | M.d | 463 | 40.05 | 0 | 12 | 194 | 18 | D | | | | | | | | | | | | | | |
5/8/26 19:03 | 5/7/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Beckerle Mary C | CA | D | | 2 | S.d | -463 | 40.05 | 0 | -12 | | 18 | D | | | | | | | | | | | | | | |
5/8/26 19:03 | 5/7/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Freire Maria C | CA | D | | 2 | M.d | 1,357 | 32.89 | 0 | 41 | 69 | 101 | D | | | | | | | | | | | | | | |
5/8/26 19:03 | 5/7/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Freire Maria C | CA | D | | 2 | S.d | -1,357 | 32.89 | 0 | -41 | | 101 | D | | | | | | | | | | | | | | |
5/8/26 19:03 | 5/7/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Poste George | CA | D | | 1 | S | -2,743 | 45.71 | 0 | -60 | | 119 | D | | | | | | | | | | | | | | |